REVIEW
Published on 03 Mar 2025
Adverse events associated with hepatic arterial infusion chemotherapy and its combination therapies in hepatocellular carcinoma: a systematic review
doi 10.3389/fimmu.2025.1531249
- 148 views
- Frontiers in Medicine
- Translational Medicine
- Research Topics
- Hepatocellular Carcinoma: Novel Treatment Strategies - Volume III
Hepatocellular Carcinoma: Novel Treatment Strategies - Volume III
7,815
Total downloads
23k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 13 Feb 2025
Creation of an innovative diagnostic framework for hepatocellular carcinoma employing bioinformatics techniques focused on senescence-related and pyroptosis-related genes
doi 10.3389/fonc.2025.1485421
- 442 views
ORIGINAL RESEARCH
Published on 10 Jan 2025
Hepatic arterial infusion chemotherapy combined with immune checkpoint inhibitors and molecular targeted therapies for advanced infiltrative hepatocellular carcinoma: a single-center experience
doi 10.3389/fimmu.2024.1474442
- 372 views
ORIGINAL RESEARCH
Published on 12 Dec 2024
Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy
doi 10.3389/fimmu.2024.1508028
- 498 views
ORIGINAL RESEARCH
Published on 12 Dec 2024
Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
doi 10.3389/fonc.2024.1495321
- 506 views
ORIGINAL RESEARCH
Published on 05 Dec 2024
Immune-checkpoint HLA-G gene polymorphisms, 3’-UTR types and their association with hepatocellular carcinoma and treatment response in Indian population
doi 10.3389/fimmu.2024.1459749
- 635 views
BRIEF RESEARCH REPORT
Published on 22 Nov 2024
Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysis
doi 10.3389/fonc.2024.1482909
- 512 views
CASE REPORT
Published on 20 Nov 2024
The survival and safety of metastatic hepatocellular carcinoma treated with lenalidomide as second-line therapy: a case report and review of the literature
doi 10.3389/fonc.2024.1461936
- 478 views
SYSTEMATIC REVIEW
Published on 11 Nov 2024
Comparison of adjuvant treatment regimens for high-risk hepatocellular carcinoma: a Bayesian network meta analysis and systematic review
doi 10.3389/fimmu.2024.1487353
- 970 views
MINI REVIEW
Published on 25 Oct 2024
Therapeutic advances in hepatocellular carcinoma: an update from the 2024 ASCO annual meeting
doi 10.3389/fonc.2024.1453412
- 2,464 views
ORIGINAL RESEARCH
Published on 03 Oct 2024
The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studies
doi 10.3389/fonc.2024.1427332
- 550 views
ORIGINAL RESEARCH
Published on 01 Oct 2024
Transarterial chemoembolization combined with lenvatinib plus tislelizumab for unresectable hepatocellular carcinoma: a multicenter cohort study
doi 10.3389/fimmu.2024.1449663
- 790 views
Published in
Frontiers in Medicine
Translational Medicine
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore